/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/e1fd6a75d37b7de752b9d8602a89e814.jpg)
[A] Growth Ventures Podcast with Hamlet Azarian
[A] Growth Ventures Podcast
How Excellis Built a Company to Sell and Kept Growing After a Strategic Exit
OCT 5, 202635 MIN
/https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/73f32a032cf97b89e09c7c2390978fcb.jpg)
Description
In this episode of the [A] Growth Ventures Podcast, Hamlet Azarian sits down with Greg Cathcart, founder of Excellis Health Solutions and now SVP and Head of NNIT US.Greg founded Excellis in 2008 to help pharmaceutical companies prepare for serialization and the Drug Supply Chain Security Act. He grew the company to about 120 people across the US, Europe, and India before selling to NNIT, a Danish IT services company, and then stayed on to lead its US business.This conversation unpacks how Greg built the company to be bought, why he walked away from a PE deal at the closing table, and what a strategic acquisition looks like from the inside. He also shares the next major shift coming for the pharma supply chain.His central insight: find the disruption early, earn credibility before the wave hits, and you'll be the one leading it when it arrives.

